Covaxin Interim Results 'Encouraging', Phase 3 Trials To Continue: AIIMS Chief

PUBLISHED ON: March 3, 2021 | Duration: 7 min, 46 sec

  
loading..
Dr Randeep Guleria, Director, AIIMS says Covaxin efficacy data is encouraging but trails will continue. This is an interim Phase 3 result based on 43 infections, but for final results, 130 infections need to be studied. But Dr Guleria says this will go a long way in promoting the vaccine program in the country.
ALSO WATCH
Data Suggests Covishield Efficacy Comes Down To 10-20% Against South African Strain: Randeep Guleria

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com